期刊
MOVEMENT DISORDERS
卷 23, 期 11, 页码 1491-1504出版社
WILEY
DOI: 10.1002/mds.21971
关键词
Huntington's disease; juvenile Huntington's disease; management; clinical features; UHDRS; biomarkers; multidisciplinary
资金
- Medical Research Council
- Huntington's Disease Foundation
- High Q Foundation
Huntingtons disease is a neurodegenerative condition. characterized by movement disorders, cognitive decline. and psychiatric disturbance. We review the pharmacological management of the various movement disorders associated with the disease. the cognitive decline and the commonly encountered behavioral disturbances. We discuss the nonclassical features of the disease. important in the management of these patients. Nonpharmacological Support including genetic counseling and therapy and the importance of palliative care are also addressed. Finally, experimental approaches that may soon impact upon clinical practice are discussed. (c) 2008 Movement Disorder Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据